SNY Dec 2024 40.000 put
| Previous Close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.0000 |
| Ask | 0.5500 |
| Strike | 40.00 |
| Expire Date | 2024-12-20 |
| Day's Range | 0.5000 - 0.5000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 20 |
BloombergSanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
(Bloomberg) -- Sanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter. Most Read from BloombergYouTuber Dr Disrespect Was Allegedly Kicked Off Twitch for Messaging MinorVW Latches Onto Rivian in $5 Billion EV Pact to Regain MomentumTrump Could Actually Lose Florida. Here’s Why.Nvidia Rout Takes Breather
GlobeNewswirePress Release: Availability of the Q2 2024 Aide-mémoire
Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2024 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
